Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data
暂无分享,去创建一个
Gianluca Bontempi | D. Franchimont | H. Nischalke | U. Spengler | J. Devière | P. Nahon | E. Falleti | P. Deltenre | L. Valenti | Christophe Moreno | P. Mathurin | P. Hillon | S. Romeo | P. Toniutto | J. Henrion | S. Corradini | E. Trépo | B. Donati | M. Burza | S. Hamza | Erwan Guyot
[1] R. Moreau,et al. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. , 2013, Journal of hepatology.
[2] H. Shiraha,et al. The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis , 2013, Journal of Gastroenterology.
[3] J. Borén,et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. , 2012, Journal of hepatology.
[4] J. Borén,et al. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[5] J. Zucman‐Rossi,et al. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. , 2012, Journal of hepatology.
[6] L. N. Valenti,et al. The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls , 2012, BMC Gastroenterology.
[7] V. Jooste,et al. 712 PNPLA 3 RS738409 GG HOMOZYGOTE STATUS IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS , 2012 .
[8] L. N. Valenti,et al. 315 I148M PNPLA3 POLYMORPHISM IS ASSOCIATED WITH CLINICAL FEATURES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA , 2012 .
[9] D. Franchimont,et al. PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis , 2012, Hepatology.
[10] F. Lammert,et al. The PNPLA3 rs738409 148M/M Genotype Is a Risk Factor for Liver Cancer in Alcoholic Cirrhosis but Shows No or Weak Association in Hepatitis C Cirrhosis , 2011, PloS one.
[11] D. Franchimont,et al. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. , 2011, Journal of hepatology.
[12] M. Pirisi,et al. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[13] M. Manns,et al. Impact of patatin‐like phospholipase‐3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C , 2011, Hepatology.
[14] S. Sookoian,et al. Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease , 2011, Hepatology.
[15] A. Molinaro,et al. Patatin‐like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma , 2011, Hepatology.
[16] A. Alisi,et al. Hepatitis C virus and alcohol: same mitotic targets but different signaling pathways. , 2011, Journal of hepatology.
[17] P. Ridker,et al. Genome-Wide Association Analysis of Soluble ICAM-1 Concentration Reveals Novel Associations at the NFKBIK, PNPLA3, RELA, and SH2B3 Loci , 2011, PLoS genetics.
[18] M. Pirisi,et al. 602 PNPLA3 RS734809 C/G POLYMORPHISM IN LIVER CIRRHOSIS: RELATIONSHIP WITH THE ETIOLOGY OF LIVER DISEASE AND HCC OCCURRENCE , 2011 .
[19] E. Galmozzi,et al. Patatin‐Like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C , 2011, Hepatology.
[20] Michael Krawczak,et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians , 2010, Hepatology.
[21] P. Haber,et al. Patatin‐like phospholipase domain containing 3: A case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease , 2010, Hepatology.
[22] E. Bugianesi,et al. Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease , 2010, Hepatology.
[23] R. Riley,et al. Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.
[24] David Kershenobich,et al. Variant in PNPLA3 is associated with alcoholic liver disease , 2010, Nature Genetics.
[25] F. Marra,et al. Adipokines in liver diseases , 2009, Hepatology.
[26] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.
[27] Douglas G. Altman,et al. Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta‐Analysis , 2008 .
[28] J. Thompson,et al. How should we use information about HWE in the meta-analyses of genetic association studies? , 2008, International journal of epidemiology.
[29] Siobhan M. Dolan,et al. Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.
[30] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[31] J. Thompson,et al. The choice of a genetic model in the meta-analysis of molecular association studies. , 2005, International journal of epidemiology.
[32] Ammarin Thakkinstian,et al. A method for meta‐analysis of molecular association studies , 2005, Statistics in medicine.
[33] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[34] John P A Ioannidis,et al. Commentary: meta-analysis of individual participants' data in genetic epidemiology. , 2002, American journal of epidemiology.
[35] L Pagliaro,et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.
[36] P. Lee,et al. Publication bias in meta-analysis: its causes and consequences. , 2000, Journal of clinical epidemiology.
[37] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[38] M. S. Patel,et al. An introduction to meta-analysis. , 1989, Health Policy.
[39] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[40] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.
[41] T. Poynard,et al. The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods. , 1985, Controlled clinical trials.
[42] D. McFadden. Conditional logit analysis of qualitative choice behavior , 1972 .
[43] H. Akaike. Fitting autoregressive models for prediction , 1969 .